Manuel
Valladares Ayerbes
Memorial Sloan Kettering Cancer Center
Nueva York, Estados UnidosPublicacións en colaboración con investigadores/as de Memorial Sloan Kettering Cancer Center (1)
2022
-
A randomised phase 2 study comparing different dose approaches of induction treatment of regorafenib in previously treated metastatic colorectal cancer patients (REARRANGE trial)
European Journal of Cancer, Vol. 177, pp. 154-163